SEC Filing Summary: Nephros, Inc. (Form 8-K)
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on May 22, 2007, with the earliest event reported on the same date. The filing addresses a change in the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
On May 22, 2007, Dr. Bernard Salick submitted his resignation from the Board of Directors, effective immediately, to pursue other business interests. The Company stated that Dr. Salick had no disagreements with the Company regarding operations, policies, or practices.
Outlook, Risks, and Management Commentary
On May 23, 2007, the Company issued a press release (Exhibit 99.1) announcing the resignation. The Board expressed gratitude for Dr. Salick's dedicated service and contributions. No specific guidance, risks, or contingencies related to future operations were detailed in this filing.
Key Facts for Investor Verification
- Dr. Bernard Salick resigned from the Board of Directors effective May 22, 2007.
- The resignation was voluntary and not due to any disagreement with the Company.
- A press release detailing the event was issued on May 23, 2007.
- The filing contains no financial data or operational outlook.